Commonwealth Equity Services’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-45
| Closed | -$4K | – | 3833 |
|
2023
Q2 | $4K | Buy |
+45
| New | +$4K | ﹤0.01% | 3817 |
|
2022
Q3 | – | Sell |
-11
| Closed | -$16K | – | 3667 |
|
2022
Q2 | $16K | Sell |
11
-3
| -21% | -$4.36K | ﹤0.01% | 3587 |
|
2022
Q1 | $29K | Sell |
14
-4
| -22% | -$8.29K | ﹤0.01% | 3630 |
|
2021
Q4 | $88K | Hold |
18
| – | – | ﹤0.01% | 3481 |
|
2021
Q3 | $113K | Buy |
18
+13
| +260% | +$81.6K | ﹤0.01% | 3394 |
|
2021
Q2 | $44K | Buy |
+5
| New | +$44K | ﹤0.01% | 3472 |
|
2018
Q2 | – | Sell |
-5
| Closed | -$55K | – | 2769 |
|
2018
Q1 | $55K | Hold |
5
| – | – | ﹤0.01% | 2588 |
|
2017
Q4 | $42K | Hold |
5
| – | – | ﹤0.01% | 2577 |
|
2017
Q3 | $11K | Hold |
5
| – | – | ﹤0.01% | 2554 |
|
2017
Q2 | $7K | Hold |
5
| – | – | ﹤0.01% | 2514 |
|
2017
Q1 | $9K | Hold |
5
| – | – | ﹤0.01% | 2409 |
|
2016
Q4 | $11K | Buy |
+5
| New | +$11K | ﹤0.01% | 2305 |
|